GLP-1 Surgery and Anesthesia Guidance: Build a Procedure-Team Plan
GLP-1 and related medicines can delay stomach emptying, which matters when anesthesia or deep sedation creates an aspiration risk. Current multi-society guidance favors an individualized procedure-team assessment rather than one universal hold interval. Patients should disclose the exact product, last use, dose-escalation phase, symptoms, and indication and then follow the surgeon, anesthesiologist, proceduralist, and prescriber's coordinated instructions.
Do not delay emergency care because of GLP-1 use; tell the emergency and anesthesia teams the exact product and last use immediately.
Board-certified urologist and robotic surgeon · Founder and Chief Medical Officer
Last reviewed July 23, 2026
- Tell every procedure team about GLP-1 or related medication use, including product, indication, schedule, last use, and recent changes.
- Current guidance says many low-risk patients can continue treatment, while higher-risk situations may require a modified plan.
- Dose escalation, significant gastrointestinal symptoms, higher exposure, and conditions that slow gastric emptying can increase concern.
- The team may consider a liquid-only diet, anesthesia-plan changes, gastric ultrasound, delay, or medication changes based on risk.
- Do not use this page to choose a hold interval; diabetes control and other risks must also be considered.
Why GLP-1 medicines matter around a procedure
These medicines can slow gastric emptying and cause nausea, vomiting, bloating, or constipation. Residual stomach contents can increase regurgitation and aspiration concern during general anesthesia and deep sedation.
Risk is not identical for every patient or procedure. The correct plan integrates symptoms, treatment phase, product, medical conditions, urgency, anesthesia type, and the reason for therapy.
Current guidance is risk-based
The 2024 multi-society guidance described by the American Society of Anesthesiologists indicates that many patients at low risk for delayed stomach emptying can continue GLP-1 therapy before elective surgery.
It also emphasizes balancing aspiration concerns against harms of withholding treatment, including glucose disruption, access problems, and other clinical consequences.
Give the team a complete medication picture
| Information | Why it matters |
|---|---|
| Exact product and indication | Different products and diabetes versus obesity treatment affect planning. |
| Schedule and last use | The team needs accurate exposure information. |
| Recent start or escalation | Early treatment and dose changes can increase gastrointestinal effects. |
| Current GI symptoms | Nausea, vomiting, bloating, pain, or constipation can signal higher risk. |
| Other conditions and medicines | Diabetes, gastroparesis, neurologic disease, and other drugs may change gastric emptying or glucose. |
| Procedure and anesthesia plan | Aspiration risk differs by procedure urgency and depth of sedation. |
Higher-risk patients may need a modified plan
The team may discuss a liquid-only diet before the procedure, point-of-care gastric ultrasound, anesthesia precautions, delaying an elective procedure, or a medication plan. Those are clinician decisions, not patient-selected options.
If a medicine is withheld, the prescriber may need to address glucose or other treatment consequences. Do not substitute another medicine without coordination.
Urgent procedures are a different situation
An emergency procedure may not allow the same preparation as elective surgery. Tell the emergency and anesthesia teams about the medication and last use immediately.
Do not delay emergency care to complete an online fasting or medication rule. The treating team will manage aspiration and metabolic risks in real time.
Get one written plan and resolve conflicts
If the prescriber, surgeon, proceduralist, or anesthesiologist gives different instructions, ask those teams to reconcile them. Do not choose the most convenient answer.
The final plan should state food and liquid instructions, medication instructions, glucose monitoring if relevant, arrival time, symptom reporting, and who can answer a last-minute question.
Frequently asked questions
Do I have to stop a GLP-1 before surgery?
Not universally. Current guidance supports individual risk assessment, so follow the procedure and prescribing teams' coordinated instructions.
Why do anesthesiologists ask about GLP-1 medications?
These medicines can delay stomach emptying, which may increase residual stomach contents and aspiration concern during anesthesia or deep sedation.
Which symptoms should I report before the procedure?
Report nausea, vomiting, bloating, abdominal pain, constipation, inability to eat, and any recent treatment or dose change.
Can I follow an old one-week hold rule?
Do not rely on a generic or outdated rule. Current planning is risk-based and should come from the responsible clinical teams.
What if my surgeon and prescriber disagree?
Ask them to coordinate with the anesthesiology or procedural team and provide one written plan.
Should I delay emergency surgery because I took a GLP-1?
No. Seek emergency care and immediately disclose the medication and last use so the team can manage the risk.
This page is educational and does not provide medical advice, diagnosis, or treatment. A clinician must evaluate your individual situation.